oseltamivir phosphate

Generic: oseltamivir phosphate

Labeler: cipla usa, inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oseltamivir phosphate
Generic Name oseltamivir phosphate
Labeler cipla usa, inc
Dosage Form FOR SUSPENSION
Routes
ORAL
Active Ingredients

oseltamivir phosphate 6 mg/mL

Manufacturer
Cipla USA, Inc

Identifiers & Regulatory

Product NDC 69097-904
Product ID 69097-904_4e8c50c0-4026-4047-ac0b-6d8bbb56f923
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212858
Listing Expiration 2026-12-31
Marketing Start 2023-01-16

Pharmacologic Class

Classes
neuraminidase inhibitor [epc] neuraminidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097904
Hyphenated Format 69097-904

Supplemental Identifiers

RxCUI
1115698
UPC
0369097904432
UNII
4A3O49NGEZ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oseltamivir phosphate (source: ndc)
Generic Name oseltamivir phosphate (source: ndc)
Application Number ANDA212858 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (69097-904-43) / 60 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

oseltamivir phosphate (6 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4e8c50c0-4026-4047-ac0b-6d8bbb56f923", "openfda": {"upc": ["0369097904432"], "unii": ["4A3O49NGEZ"], "rxcui": ["1115698"], "spl_set_id": ["7d04f367-8f62-4f63-bac9-717d14f555a5"], "manufacturer_name": ["Cipla USA, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (69097-904-43)  / 60 mL in 1 BOTTLE", "package_ndc": "69097-904-43", "marketing_start_date": "20230116"}], "brand_name": "OSELTAMIVIR PHOSPHATE", "product_id": "69097-904_4e8c50c0-4026-4047-ac0b-6d8bbb56f923", "dosage_form": "FOR SUSPENSION", "pharm_class": ["Neuraminidase Inhibitor [EPC]", "Neuraminidase Inhibitors [MoA]"], "product_ndc": "69097-904", "generic_name": "OSELTAMIVIR PHOSPHATE", "labeler_name": "Cipla USA, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OSELTAMIVIR PHOSPHATE", "active_ingredients": [{"name": "OSELTAMIVIR PHOSPHATE", "strength": "6 mg/mL"}], "application_number": "ANDA212858", "marketing_category": "ANDA", "marketing_start_date": "20230116", "listing_expiration_date": "20261231"}